IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin

The complexity of the IGF-1 signalling axis is clearly a roadblock in targeting this receptor in cancer therapy. Here, we sought to identify mediators of resistance, and potential co-targets for IGF-1R inhibition. By using an siRNA functional screen with the IGF-1R tyrosine kinase inhibitor (TKI) BM...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Flanagan, Ciara H., O'shea, Sandra, Lyons, Amy, Fogarty, Fionola M., McCabe, Nuala, Kennedy, Richard D., O'Connor, Rosemary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302955/
https://www.ncbi.nlm.nih.gov/pubmed/27472395
http://dx.doi.org/10.18632/oncotarget.10862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302955/
https://www.ncbi.nlm.nih.gov/pubmed/27472395
http://dx.doi.org/10.18632/oncotarget.10862

Ejemplares similares